¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"combined ventricular hypertrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • combined sclerosis
    ¿¬ÇÕ°æÈ­Áõ
  • combined spinal epidural anesthesia
    ôÃ߰渷¿Üº´¿ë¸¶Ãë
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·º´
  • subacute combined degeneration
    ¾Æ±Þ¼º¿¬ÇÕº¯¼º
  • severe combined immunodeficiency disease
    ÁßÁõº¹Çո鿪°áÇ̺´
  • bidirectional ventricular tachycardia
    ¾ç¹æÇâ½É½Çºü¸¥¸Æ, ¾ç¹æÇâ½É½Ç(¼º)ºó¸Æ
  • escaped ventricular contraction
    ÀÌÅ»½É½Ç¼öÃà
  • left ventricular failure
    ¿Þ½É½Ç±â´É»ó½Ç, Á½ɽǺÎÀü
  • premature ventricular contraction
    Á¶±â½É½Ç¼öÃà
  • right ventricular failure
    ¿À¸¥½É½Ç±â´É»ó½Ç, ¿ì½É½ÇºÎÀü
  • right ventricular strain
    ¿ì½É½Ç±äÀå, ¿À¸¥½É½Ç±äÀå
  • ventricular
    1. ½É½Ç- 2. ³ú½Ç-
  • ventricular activation
    ½É½ÇȰ¼ºÈ­
  • ventricular activation time
    ½É½ÇÈïºÐ½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • combined sensation
    º¹ÇÕ°¨°¢
  • combined version
    º¹ÇÕȸÀü(¼ú), º¹ÇÕžÆÈ¸Àü
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • combined manual reposition
    µ¿¹Ýµµ¼öÁ¤º¹
  • combined modality therapy
    º´¿ë¿ä¹ý
  • combined plantar sign
    ¿¬Çչ߹ٴÚ¡ÈÄ
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·Áõ, º¹ÇÕÆÇ¸·º´
  • subacute combined degeneration
    ¾Æ±Þ¼º¿¬ÇÕº¯¼º
  • ventricular activation
    ½É½ÇÈïºÐ
  • ventricular aneurysm
    ½É½ÇÀÚ·ç, ½É½Ç·ù
  • ventricular arrhythmia
    ½É½ÇºÎÁ¤¸Æ
  • ventricular asynergy
    ½É½ÇÇùµ¿ºÒ´É
  • ventricular bulge
    ½É½ÇÆØÃâ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • combined pelvimetry
    º¹ÇÕ¼º °ñ¹Ý°èÃø¹ý.
  • combined plantar sign
    ¿¬ÇÕ¼º Á·Àú¡ÈÄ(æáùêàõðëî¼ó£ý¦).
  • combined podalic version
    º¹ÇÕ¼º Á·ºÎÀÌ¿ëȸÀü¼ú, ½ÖÇÕÁ·À§È¸Àü¼ú.
  • combined scintiscan
    º´Çսů¼½ºÄµ.
  • combined sclerosis
    º´ÇÕ°æÈ­Áõ(ܱùê Ìãûùñø).
  • combined sewer
    ÇÕ·ù½Ä Çϼö±¸(̰ËôËà ̰ËàË´).
  • combined system disease
    º¹ÇÕ°èÅëÁúȯ.
  • combined vaccine
    È¥ÇÕ(ûèùê)¿ÎÁø.
  • combined vaccine
    º¹ÇÕ¹é½Å
  • combined valvular disease
    º¹ÇÕÆÇ¸·Áúȯ.
  • combined ventilatory defect
    º¹ÇÕ¼ºÈ¯±âÀå¾Ö
  • combined version
    º¹ÇÕ¼º ȸÀü¼ú.
  • combined waste water treatment
    °øµ¿Æó¼öó¸®(Ë­ËÄ̰Ëà̧Ëö).
  • combined water
    È­ÇÕ¼ö(ûùùêâ©).
  • combined width of lateral segment teeth
    Ãø¹æÄ¡±ºÀå(ö°Û°öÍÏØíþ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AMI Acute Myocardial Infarction
  - Complications(Cx)
    1. Early ...
VF left leg [electrode]; ventricular fibrillation; ventricular fluid; ventricular flutter; visual field...
AH   1) Atrial Hypertrophy
  2) Anti-Hyaluronidase
  3) Amyloid imm...
ASH Asymmetric(al) Septal Hypertrophy
BPH Benign Prostate(Prostatic) Hypertrophy(Hyperplasia); Àü¸³¼± ºñ´ë(Áõ)
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CSE Combined Spinal-Epidural
CAB Combined androgen blockade
CCT Combined cortical thickness
CHL Combined hyperlipidemia
CID Combined immunodeficiency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ventricular
    ½É½ÇÀÇ
    ½É½Ç¿¡ °üÇÑ.
  • ventricular fibrillation
    ½É½Ç ¼¼µ¿
    ½ÉÀåÀÇ ¹Úµ¿¿¡¼­ ½É½ÇÀÇ °¢ ºÎºÐÀÌ ¹«Áú¼­ÇÏ°Ô ºÒ±ÔÄ¢ÀûÀ¸·Î ¼öÃàÇÏ´Â »óÅÂ. ¼öÃàÀÇ ºóµµ, Áï ½ÉÀüµµ»óÀÇ ÆÄ»óÀÌ ¸ÅºÐ 170¡­300ÀÎ °ÍÀ» Á¶µ¿, 300¡­600ÀÎ °ÍÀ» ¼¼µ¿À̶ó ÇÏ¿© ±¸º°ÇÏ´Â °æ¿ìµµ ÀÖÀ¸³ª, ½É½Ç Á¶µ¿¿¡´Â Áֱ⿡ È®½ÇÇÑ ±ÔÄ¢¼ºÀÌ ¾øÀ¸¹Ç·Î ½É½Ç¿¡ °üÇÏ¿© ¼¼µ¿°ú Á¶µ¿ »çÀÌ¿¡´Â ¶Ñ·ÇÇÑ ±¸º°ÀÌ ¾ø´Ù. ½É½Ç ¼¼µ¿ÀÏ ¶§´Â ½É½Ç¿¡¼­ Ç÷¾×ÀÌ ¹ÚÃâµÇÁö ¾ÊÀ¸¹Ç·Î ¼øÈ¯ºÎÀüÀ» ÀÏÀ¸ÄѼ­ »ç¸ÁÇÏ°Ô µÈ´Ù. À̶§´Â ½ÉÀå ¸¶»çÁö¸¦ Çϰųª Á¦¼¼µ¿±â¿¡ ÀÇÇÏ¿© ¼¼µ¿À» Á¦°ÅÇØ¾ß ÇÑ´Ù.
  • ventricular gallop
    ½É½Ç¼º °¶·´, ½É½Ç¼º ºÐ¸¶À²
  • ventricular septal defect
    ½É½Ç Áß°Ý °á¼Õ
    ¼±Ãµ¼º ½ÉÁúȯ¿¡¼­ ºóµµ°¡ ³ôÀº °ÍÀÇ ÇϳªÀÌ´Ù. ½É½Ç Áß°Ý¿¡ °á¼ÕÀÌ ÀÖ´Â °ÍÀ» ¸»ÇÑ´Ù. º¸Åë ½É½Ç Áß°Ý ¸·¼º ºÎÀ§ÀÇ °á¼ÕÀε¥ ±Ù¼º ºÎÀ§¿¡ °á¼ÕÀÌ ÀÖ´Â °Íµµ ÀÖ´Ù. °á¼Õ°øÀÇ Å©±â´Â ´Ù¾çÇÏ´Ù. ÀϹÝÀûÀ¸·Î ¿¹ÈÄ´Â ¾çÈ£Çϰí ÀÚ¿¬ Æó¼âµµ ÀÖ´Ù. Ä¡·á´Â ¿Ü°úÀûÀ¸·Î Æó¼â¸¦ ÇÑ´Ù.
  • ventricular vein
    ½É½Ç Á¤¸Æ
  • adaptive hypertrophy
    ¼øÀÀ¼º ºñ´ë
    »óÅÂÀÇ º¯È­¿¡ ÀÇÇÏ¿© Å©±â°¡ Áõ°¡ÇÏ´Â °Í.
  • adenoidal hypertrophy
    ¾Æµ¥³ëÀÌµå ºñ´ëÁõ
  • asymmetric septal hypertrophy
    ºñ´ëμº Áß°Ý ºñ´ëÁõ, ºñ´ëĪ Áß°Ý ºñÈÄ
  • benign masseteric hypertrophy
    ¾ç¼º ±³±Ù ºñ´ë
    ¿øÀÎ ºÒ¸íÀÇ ÁúȯÀ¸·Î¼­, º¸Åë ¾çÃø¼ºÀ¸·Î ±³±ÙÀÇ Å©±â°¡ ºñ¾Ç¼ºÀ¸·Î Áõ°¡ÇÑ´Ù.
  • benign prostatic hypertrophy
    ¾ç¼º Àü¸³¼± ºñ´ë, ¾ç¼º Àü¸³¼± ºñ´ëÁõ
  • compensatory hypertrophy
    º¸»ó¼º ºñ´ë
  • concentric hypertrophy
    µ¿½É¼º ºñ´ë
  • contralateral hypertrophy
    ´ëμº ºñ´ë
    ´Ù¸¥ ÇÑ ÂÊÀÇ ºñ´ë.
  • hypertrophy of dental root
    Ä¡±Ù ºñ´ë
  • muscular hypertrophy
    ±ÙÀ° ºñ´ëÁõ, ±ÙÀ° ºñ´ë, ±Ù ºñ´ë
    ±Ù ºñ´ë´Â ±Ù ¼¶À¯ÀÇ Å©±âÀÇ Áõ°¡¸¦ ÀǹÌÇÑ´Ù. Áö¹æ ħÀ±, Á¾¾ç, ¿°Áõ¼º º´º¯¿¡ µû¸¥ ¿Ü°ß»ó ºñ´ë¸¦ °¡¼º ºñ´ë¶ó°í ÇÏ°í »ç½Ç»óÀÇ ºñ´ë¿Í ±¸º°ÇÑ´Ù. °Ç°­ÇÑ ±ÙÀ°µµ Àå±â¿¡ °ÉÄ£ °úÀ× ÀÛ¾÷À¸·Î ÀÎÇØ ºñ´ë¸¦ ÀÏÀ¸Å²´Ù. ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõÀÇ °æ¿ì ºñÀå±ÙÀÇ ºñ´ë°¡ Á¾Á¾ ù Áõ»óÀÌ µÈ´Ù. ¼±Ãµ¼º ±Ù ±äÀåÁõ¿¡¼­µµ ±Ù ºñ´ë¸¦ º¸°Ô µÈ´Ù. ±Ù ºñ´ë¿¡´Â ³²¼º È£¸£¸ó µîÀÇ ³»ºÐºñ ÀÎÀÚµµ Áß¿äÇÑ ¿ªÇÒÀ» Áö´Ñ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
benign prostatic hypertrophy <urology> A benign enlargement of the prostate gland begins normally after age 50 years probably secondary to the effects of male hormones. If significant enlargement occurs, it may pinch off te urethra making urination difficult or impossible.
See: urinary retention.
(06 Aug 1998)
giant hypertrophy of gastric mucosa Gastric mucosal hyperplasia, either mucoid or glandular; the latter type may be associated with the Zollinger-Ellison syndrome.
Synonym: giant hypertrophy of gastric mucosa, hypertrophic gastritis, Menetrier's syndrome.
(05 Mar 2000)
gingival hypertrophy <dentistry> The abnormal enlargement of the gingiva surrounding the teeth caused by poor oral hygiene.
(08 Jan 1998)
vicarious hypertrophy Hypertrophy of an organ following failure of another organ because of a functional relationship between them; e.g., enlargement of the pituitary gland, after destruction of the thyroid.
(05 Mar 2000)
physiologic hypertrophy Temporary increase in size of an organ or part to provide for a natural increase of function, such as the kind that occurs in the walls of the uterus and in the mammae during pregnancy.
Synonym: functional hypertrophy.
(05 Mar 2000)
compensatory hypertrophy Increase in size of an organ or part of an organ or tissue, when called upon to do additional work or perform the work of destroyed tissue or of a paired organ.
(05 Mar 2000)
compensatory hypertrophy of the heart Thickening of the walls of the heart in response to vascular, valvular, other heart disease, or athletic conditioning.
(05 Mar 2000)
complementary hypertrophy Increase in size or expansion of part of an organ or tissue to fill the space left by the destruction of another portion of the same organ or tissue.
(05 Mar 2000)
concentric hypertrophy Thickening of the walls of the heart or any cavity with apparent diminution of the capacity of the cavity.
(05 Mar 2000)
haemangiectatic hypertrophy <syndrome> A congenital malformation syndrome characterised by the triad of asymmetric limb hypertrophy, haemangiomata, and nevi. Asymmetric limb hypertrophy is enlargement of one limb and not the corresponding limb on the other side, the enlarged limb being 3 times more likely to be a leg than an arm in ktw; and the limb enlargement is of bone as well as soft tissue. The haemangiomas, abnormal nests of blood vessels that proliferate inappropriately and excessively, cover a remarkable range from small innocuous capillary haemangiomas ( strawberry marks ) to huge cavernous haemangiomas. The nevi are pigmented moles on the skin; in ktw there are often also dark linear streaks on the skin, streaks due to too much pigment. There can be other abnormalities but the triad is the consistent clinical centrepiece of the disease. most persons with ktw have an enlarged leg and do relatively well without treatment or, for example, with only compression from an elastic stocking. Skin ulcers and other skin problems can occur over the swollen leg. Usually, the treatment is conservative. Surgery is almost never needed. The only possible exceptions are the very rare situations in which the leg reaches gigantic proportions or secondary clotting difficulties arise (due to trapping and destruction of blood platelets in a huge haemangioma). Then, amputation may become necessary. The cause of ktw syndrome is unknown.
(12 Dec 1998)
simple hypertrophy Increase in size of cells.
(05 Mar 2000)
simulated hypertrophy Increased size of a part due to continued growth unrestrained by attritions, as is seen in the case of the teeth of certain animals when the opposing teeth have been destroyed.
(05 Mar 2000)
hypertrophy The enlargement or overgrowth of an organ or part due to an increase in size of its constituent cells.
Compare: hyperplasia.
Origin: Gr. Troph = nutrition
(18 Nov 1997)
numerical hypertrophy <pathology> The abnormal multiplication or increase in the number of normal cells in normal arrangement in a tissue.
Compare: hypertrophy.
Origin: Gr. Plasis = formation
(18 Nov 1997)
quantitative hypertrophy <pathology> The abnormal multiplication or increase in the number of normal cells in normal arrangement in a tissue.
Compare: hypertrophy.
Origin: Gr. Plasis = formation
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á